公开(公告)号：US11786402B2

公开(公告)日：2023-10-17

申请号：US17149834

申请日：2021-01-15

Applicant: Alcon Inc.

Inventor： Eugene de Juan, Jr. ,  Stephen Boyd ,  Mark E. Deem ,  Hanson S. Gifford, III ,  Dan Rosenman

IPC: A61F9/007 ,  A61F9/00 ,  A61F11/00 ,  A61K9/00 ,  A61B34/00 ,  A61B90/00 ,  A61F9/013 ,  A61M27/00 ,  A61F2/14

CPC classification number: A61F9/00781 ,  A61B34/70 ,  A61B90/00 ,  A61F9/007 ,  A61F9/0008 ,  A61F9/0017 ,  A61F9/00736 ,  A61F11/00 ,  A61K9/0051 ,  A61F2/14 ,  A61F2/142 ,  A61F9/0133 ,  A61F2250/0001 ,  A61F2250/0096 ,  A61F2250/0097 ,  A61M27/002 ,  A61M2202/04 ,  A61M2210/0612

Abstract: Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye. The shunt includes a fluid passageway. The shunt is passed along a pathway from the anterior chamber through the scleral spur of the eye into the suprachoroidal space and positioned in a first position such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber.

公开(公告)号：US11344448B2

公开(公告)日：2022-05-31

申请号：US16704902

申请日：2019-12-05

Applicant: Alcon Inc.

Inventor： Thomas A. Silvestrini ,  Eugene de Juan, Jr.

IPC: A61F9/007

Abstract: Described herein are devices and methods for treating eye conditions. Described is an ocular implant including an elongate member having an internal lumen forming a flow pathway, at least one inflow port communicating with the flow pathway, and at least one outflow port communicating with the flow pathway. The elongate member is adapted to be positioned in the eye such that at least one inflow port communicates with the anterior chamber, at least one outflow port communicates with the suprachoroidal space to provide a fluid pathway between the anterior chamber and the suprachoroidal space when the elongate member is implanted in the eye. The elongate member has a wall material imparting a stiffness to the elongate member. The stiffness is selected such that after implantation the elongate member deforms eye tissue surrounding the suprachoroidal space forming a tented volume.

公开(公告)号：US10905590B2

公开(公告)日：2021-02-02

申请号：US15710618

申请日：2017-09-20

Applicant: Alcon Inc.

Inventor： Eugene de Juan, Jr. ,  Stephen Boyd ,  Mark E. Deem ,  Hanson S. Gifford, III ,  Dan Rosenman

IPC: A61F9/007 ,  A61F9/00 ,  A61F11/00 ,  A61K9/00 ,  A61B34/00 ,  A61B90/00 ,  A61F9/013 ,  A61M27/00 ,  A61F2/14

Abstract: Methods and devices are adapted for implanting into the eye. An incision is formed in the cornea of the eye and a shunt is inserted through the incision into the anterior chamber of the eye. The shunt includes a fluid passageway. The shunt is passed along a pathway from the anterior chamber through the scleral spur of the eye into the suprachoroidal space and positioned in a first position such that a first portion of the fluid passageway communicates with the anterior chamber and a second portion of the fluid passageway communicates with the suprachoroidal space to provide a fluid passageway between the suprachoroidal space and the anterior chamber.